Greystone Financial Group, LLC Bristol Myers Squibb CO Transaction History

Greystone Financial Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$57.89 - $64.73 $77,225 - $86,349	1,334 Added 2.43%	56,250 $3.26 Million
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $3.5 Million - $3.88 Million	54,916 New	54,916 $3.51 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $8.55 Million - $9.42 Million	-117,798 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $77,772 - $93,255	-1,265 Reduced 1.06%	117,798 $8.6 Million
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $1.4 Million - $1.63 Million	26,071 Added 28.04%	119,063 $7.42 Million
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $810,569 - $949,477	-13,699 Reduced 12.84%	92,992 $5.5 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $43,894 - $47,800	709 Added 0.67%	106,691 $7.13 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $6.29 Million - $7.07 Million	105,982 New	105,982 $6.81 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Greystone Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Greystone Financial Group, LLC with notifications on news.